Why the Avandia scandal proves big pharma needs stronger ethical standards.
Sean
S
Philpott
Robert
R
Baker
D002318:Cardiovascular Diseases / Q000139:chemically induced*; D004341:Drug Evaluation; D004345:Drug Industry / Q000941:ethics*; D004335:Drug and Narcotic Control; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D000077154:Rosiglitazone; D045162:Thiazolidinediones / Q000009:adverse effects*; D035502:Trust; D014342:Truth Disclosure / Q000941:ethics; D014481:United States
D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077154:Rosiglitazone